Investegate |Arecor Limited Announcements | Arecor Limited: Arecor AT247 PhI Data Published in Diabetes Care
AT247, a promising candidate in the pursuit for next generation insulins to improve glycemic control Cambridge, UK, 16 December 2020: Arecor Limited ("Arecor" or "the Company"), the biopharmaceutical company advancing today's therapies to enable healthier lives, today announces that Diabetes Care has published data for the Phase I clinical trial of AT247, its ultra-rapid acting insulin product candidate. The manuscript titled 'Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A R...
Source: investegate.co.uk